Nasdaq Crbu News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Caribou Biosciences (NASDAQ:CRBU – Get Free Report) and iTeos Therapeutics (NASDAQ:ITOS – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, earnings, profitability, institutional ownership, valuation and analyst recommendations. Earnings & Valuation This table compares Caribou […]

Abrdn plc purchased a new stake in shares of Caribou Biosciences, Inc. (NASDAQ:CRBU – Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor purchased 181,487 shares of the company’s stock, valued at approximately $1,040,000. Several other institutional investors have also added to or reduced their stakes […]

Caribou Biosciences (NASDAQ:CRBU – Get Free Report) and iTeos Therapeutics (NASDAQ:ITOS – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, risk, dividends, valuation and analyst recommendations. Earnings and Valuation This table compares Caribou […]

Caribou Biosciences, Inc. (NASDAQ:CRBU – Get Free Report)’s share price traded up 6.5% during trading on Monday . The stock traded as high as $5.59 and last traded at $5.57. 298,268 shares were traded during mid-day trading, a decline of 82% from the average session volume of 1,614,575 shares. The stock had previously closed at […]

Silverarc Capital Management LLC purchased a new position in shares of Caribou Biosciences, Inc. (NASDAQ:CRBU – Free Report) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 892,786 shares of the company’s stock, valued at approximately $4,268,000. A number of other large investors have also […]